What are the generic alternatives for Glycophos Concentrate for Solution for Infusion 216mg/ml in Malaysia?

There are 1 approved pharmaceutical formulations registered in Malaysia containing the same active ingredient (Sodium Glycerophosphate), which can be compared for cost and availability.

MAL20020899ACRZPrescription (MAL-A)

Glycophos Concentrate for Solution for Infusion 216mg/ml

Q: Is Glycophos Concentrate for Solution for Infusion 216mg/ml approved by KKM / NPRA in Malaysia?

Yes, Glycophos Concentrate for Solution for Infusion 216mg/ml is officially registered with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia under registration number MAL20020899ACRZ with status "PRODUCT APPROVED".

Q: What are the active ingredients of Glycophos Concentrate for Solution for Infusion 216mg/ml?

The active ingredients of Glycophos Concentrate for Solution for Infusion 216mg/ml as declared to NPRA are: Sodium Glycerophosphate 216MG/ML.

Generic Molecule: Sodium Glycerophosphate

ACTIVE & APPROVEDValid till: 14 Aug 2027

NPRA Official Regulatory Summary

Glycophos Concentrate for Solution for Infusion 216mg/ml is a KKM-approved Prescription Medicine registered under MAL number MAL20020899ACRZ by FRESENIUS KABI MALAYSIA SDN. BHD. Its active ingredient is Sodium Glycerophosphate 216MG/ML, manufactured by HP Halden Pharma AS.

Holder (PRH)

FRESENIUS KABI MALAYSIA SDN. BHD

Manufacturer

HP Halden Pharma AS

First Registered

14 Aug 2022

Validity

14 Aug 2027

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

1 Component

Active Substance / Molecule	Declared Strength / Dosage	Generic Directory
Sodium Glycerophosphate	216MG/ML	Find Brands

Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Sole Registered Brand Formulation

This product is currently the primary or innovator formulation registered in Malaysia under Sodium Glycerophosphate.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL20020899ACRZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).

Frequently Asked Questions & Verification Details

Is Glycophos Concentrate for Solution for Infusion 216mg/ml approved by KKM / NPRA?

Yes. Glycophos Concentrate for Solution for Infusion 216mg/ml is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL20020899ACRZ with current status PRODUCT APPROVED. Registration was filed by FRESENIUS KABI MALAYSIA SDN. BHD.

What are the active ingredients of Glycophos Concentrate for Solution for Infusion 216mg/ml?

The declared active therapeutic components are: Sodium Glycerophosphate 216MG/ML. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 1 registered brand formulations containing identical active ingredients (Sodium Glycerophosphate). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Glycophos Concentrate for Solution for Infusion 216mg/ml (MAL20020899ACRZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.